Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)
Others
Ratios

Volitionrx (VNRX) Cost of Revenue (2019 - 2025)

Historic Cost of Revenue for Volitionrx (VNRX) over the last 7 years, with Q3 2025 value amounting to $958567.0.

  • Volitionrx's Cost of Revenue fell 901.85% to $958567.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $4.2 million, marking a year-over-year decrease of 3061.61%. This contributed to the annual value of $5.4 million for FY2024, which is 2160.88% down from last year.
  • Latest data reveals that Volitionrx reported Cost of Revenue of $958567.0 as of Q3 2025, which was down 901.85% from $1.0 million recorded in Q2 2025.
  • Volitionrx's Cost of Revenue's 5-year high stood at $1.9 million during Q4 2023, with a 5-year trough of $427401.0 in Q1 2021.
  • Its 5-year average for Cost of Revenue is $1.3 million, with a median of $1.5 million in 2022.
  • As far as peak fluctuations go, Volitionrx's Cost of Revenue soared by 43603.84% in 2021, and later tumbled by 4516.28% in 2025.
  • Volitionrx's Cost of Revenue (Quarter) stood at $1.8 million in 2021, then dropped by 7.65% to $1.7 million in 2022, then grew by 13.15% to $1.9 million in 2023, then plummeted by 34.08% to $1.3 million in 2024, then fell by 23.42% to $958567.0 in 2025.
  • Its Cost of Revenue was $958567.0 in Q3 2025, compared to $1.0 million in Q2 2025 and $917299.0 in Q1 2025.